Document Detail


The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase.
MedLine Citation:
PMID:  15161667     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Primary drug resistance is a major problem in multiple myeloma, an incurable disease of the bone marrow. Cell adhesion-mediated drug resistance (CAM-DR) causes strong primary resistance. By coculturing multiple myeloma cells with bone marrow stromal cells (BMSCs), we observed a CAM-DR of about 50% to melphalan, treosulfan, doxorubicin, dexamethasone, and bortezomib, which was not reversed by secreted soluble factors. Targeting the adhesion molecules lymphocyte function-associated antigen 1 (LFA-1) and very late antigen 4 (VLA-4) by monoclonal antibodies or by the LFA-1 inhibitor LFA703 reduced CAM-DR significantly. Only statins such as simvastatin and lovastatin, however, were able to completely restore chemosensitivity. All these effects were not mediated by deadhesion or reduced secretion of interleukin 6. Targeting geranylgeranyl transferase (GGTase) and Rho kinase by specific inhibitors (GGTI-298 and Y-27632), but not inhibition of farnesyl transferase (FTase) by FTI-277, showed similar reduction of CAM-DR. Addition of geranylgeranyl pyrophosphate (GG-PP), but not of farnesyl pyrophosphate (F-PP), was able to inhibit simvastatin-induced CAM-DR reversal. Our data suggest that the 3-hydroxy-3-methylglutaryl-coenzyme-A (HMG-CoA)/GG-PP/Rho/Rho-kinase pathway mediates CAM-DR and that targeting this pathway may improve the efficacy of antimyeloma therapies by reduction of CAM-DR.
Authors:
Ralf Schmidmaier; Philipp Baumann; Meral Simsek; Farshid Dayyani; Bertold Emmerich; Gerold Meinhardt
Related Documents :
11739097 - High glucose-enhanced activation of mesangial cell p38 mapk by et-1, ang ii, and platel...
6182337 - Renin-angiotensin influences on tubuloglomerular feedback activity in the rat.
15182187 - Calmodulin involvement in stress-activated nuclear localization of albumin in jb6 epith...
8897827 - Mechanisms of ang ii-induced mitogenic responses: role of 12-lipoxygenase and biphasic ...
8424107 - Multiple pathways lead to activation of the survival mechanism in quiescent balb/c-3t3 ...
9790917 - The src-like tyrosine kinase hck is activated by granulocyte colony-stimulating factor ...
Publication Detail:
Type:  Journal Article     Date:  2004-05-25
Journal Detail:
Title:  Blood     Volume:  104     ISSN:  0006-4971     ISO Abbreviation:  Blood     Publication Date:  2004 Sep 
Date Detail:
Created Date:  2004-09-02     Completed Date:  2004-10-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1825-32     Citation Subset:  AIM; IM    
Affiliation:
Laboratory for Molecular Haematology, Department of Haematology and Oncology, Klinikum der Universität München, Medizinische Klinik-Innenstadt, Ziemssenstrasse 1, 80336 Munich, Germany. ralf.schmidmaier@med.uni-muenchen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bone Marrow Cells / drug effects
Cell Adhesion / drug effects
Cell Line, Tumor
Drug Resistance, Multiple / drug effects
Drug Resistance, Neoplasm* / drug effects
Enzyme Activation / drug effects
Humans
Hydroxymethylglutaryl CoA Reductases / metabolism
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
Intracellular Signaling Peptides and Proteins
Multiple Myeloma / metabolism*,  pathology*
Protein Prenylation / drug effects
Protein-Serine-Threonine Kinases / metabolism*
Signal Transduction
Simvastatin / pharmacology*
rho GTP-Binding Proteins / metabolism*
rho-Associated Kinases
Chemical
Reg. No./Substance:
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Intracellular Signaling Peptides and Proteins; 79902-63-9/Simvastatin; EC 1.1.1.-/Hydroxymethylglutaryl CoA Reductases; EC 2.7.11.1/Protein-Serine-Threonine Kinases; EC 2.7.11.1/rho-Associated Kinases; EC 3.6.5.2/rho GTP-Binding Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Integrin alpha4beta7 and its counterreceptor MAdCAM-1 contribute to hematopoietic progenitor recruit...
Next Document:  A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimu...